Cel­gene pays $50M to tie up with four big can­cer re­search cen­ters

The top re­search in­sti­tu­tions have played a lead­ing role in the de­vel­op­ment of a full slate of new can­cer ther­a­pies in re­cent years. And now Cel­gene has forked out $50 mil­lion to set up a con­sor­tium that will bring to­geth­er some of those in­sti­tu­tions’ top in­ves­ti­ga­tors to­geth­er for the Big Biotech’s work in the field.

Cel­gene hand­ed out $12.5 mil­lion each to the Abram­son Can­cer Cen­ter at the Uni­ver­si­ty of Penn­syl­va­nia, The Her­bert Irv­ing Com­pre­hen­sive Can­cer Cen­ter at Co­lum­bia Uni­ver­si­ty Med­ical Cen­ter, the Sid­ney Kim­mel Com­pre­hen­sive Can­cer Cen­ter at Johns Hop­kins, and The Tisch Can­cer In­sti­tute at the Ic­ahn School of Med­i­cine at Mount Sinai to cre­ate the group.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER